Evidence map›Paper›PMID 27113631›Full record

ArticleJournal of cellular and molecular medicine2016

Interaction of uromodulin and complement factor H enhances C3b inactivation.

Maojing Liu, Yaqin Wang, Fengmei Wang, Min Xia, Ying Liu, Yuqing Chen, Ming-Hui Zhao

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maojing LiuRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Yaqin WangRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Fengmei WangRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Min XiaRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Ying LiuRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Yuqing ChenRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China. cyq@bjmu.edu.cn.
Ming-Hui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Peking University First Hospital · CNMinistry of Education of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies suggest that uromodulin plays an important role in chronic kidney diseases. It can interact with several complement components, various cytokines and immune system cells. Complement factor H (CFH), as a regulator of the complement alternative pathway, is also associated with various renal diseases. Thus, we have been suggested that uromodulin regulates complement activation by interacting with CFH during tubulointerstitial injury. We detected co-localization of uromodulin and CFH in the renal tubules by using immunofluorescence. Next, we confirmed the binding of uromodulin with CFH in vitro and found that the affinity constant (KD ) of uromodulin binding to CFH was 4.07 × 10(-6) M based on surface plasmon resonance results. The binding sites on CFH were defined as the short consensus repeat (SCR) units SCR1-4, SCR7 and SCR19-20. The uromodulin-CFH interaction enhanced the cofactor activity of CFH for factor I-mediated cleavage of C3b to iC3b. These results indicate that uromodulin plays a role via binding and enhancing the function of CFH.

Indexed as

Complement C3bComplement Factor HFemaleHumansKidney TubulesMaleProtein BindingSurface Plasmon ResonanceUromodulinComplement C3bComplement Factor HUromodulinchronic kidney diseasecomplement factor HTamm-Horsfall proteinuromodulin

Identifiers

PMID27113631
PMCPMC5020621
OpenAlexW2344843858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.